Breaking News Instant updates and real-time market news.

09:05
05/01/20
05/01
09:05
05/01/20
09:05

U.S. equity futures are weaker

U.S. equity futures are weaker, extending losses seen in regular trading yesterday as risk-aversion picked-up overnight. The Dow mini is down -1.9%, the S&P 500 mini is off -2.1% and the NASDAQ mini has contracted -2.4% in pre-market futures trading. Earnings news from Apple and Amazon yesterday after the close showed a hit from the coronavirus and related containment measures, added to selling pressure. Meanwhile, worries over the effects of the pandemic have been exacerbated by concerns over the increasing possibility of resurgent U.S.-China frictions. Indeed, President Trump threatened China with new tariffs in retaliation for the coronavirus. May Day holidays have thinned trading, shutting most European markets -- only the UK's FTSE is open and it has fallen -1.9%. Asian stock markets closed with mixed results, as Japan's Nikkei tumbled -2.8%, but China's CSI 300 rose 1.2% and Hong Kong's Hang Seng edged up 0.3%. The earnings slate is heavy on energy today, featuring Exxon Mobil, Chevron, Novo Nordisk, Phillips 66, and Imperial Oil. Also of interest are AbbVie, Charter communications, HSBC, Honeywell, Colgate-Palmolive, Estee Lauder, Aon, Phillips 66, Clorox, Johnson Controls, Weyerhaeuser, DISH Network, and Cboe

TODAY'S FREE FLY STORIES

Technical Analysis
Market Vectors Semiconductor: Pivot points » 08:21
03/05/21
03/05
08:21
03/05/21
08:21
SMH

Market Vectors Semiconductor

$221.70 /

-11.06 (-4.75%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMH Market Vectors Semiconductor
$221.70 /

-11.06 (-4.75%)

SMH Market Vectors Semiconductor
$221.70 /

-11.06 (-4.75%)

Technical Analysis
Invesco QQQ Trust: Pivot points » 08:20
03/05/21
03/05
08:20
03/05/21
08:20
QQQ

Invesco QQQ Trust

$304.06 /

-5.14 (-1.66%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QQQ Invesco QQQ Trust
$304.06 /

-5.14 (-1.66%)

QQQ Invesco QQQ Trust
$304.06 /

-5.14 (-1.66%)

QQQ Invesco QQQ Trust
$304.06 /

-5.14 (-1.66%)

Technical Analysis
Nasdaq Composite: Pivot points » 08:20
03/05/21
03/05
08:20
03/05/21
08:20
$COMP

Nasdaq Composite

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$COMP Nasdaq Composite
$0.00 /

+ (+0.00%)

Technical Analysis
Nasdaq 100 Index: Pivot points » 08:20
03/05/21
03/05
08:20
03/05/21
08:20
NDX

Nasdaq 100 Index

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDX Nasdaq 100 Index
$0.00 /

+ (+0.00%)

Downgrade
GPT Group downgraded to Hold from Buy at Jefferies » 08:18
03/05/21
03/05
08:18
03/05/21
08:18
GPTGF

GPT Group

$0.00 /

+ (+0.00%)

Jefferies analyst Sholto…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GPTGF GPT Group
$0.00 /

+ (+0.00%)

10/29/20 Jefferies
GPT Group downgraded to Hold from Buy at Jefferies
06/09/20 Jefferies
GPT Group downgraded to Hold from Buy at Jefferies
Upgrade
Seres Therapeutics upgraded to Buy from Neutral at Chardan » 08:17
03/05/21
03/05
08:17
03/05/21
08:17
MCRB

Seres Therapeutics

$18.01 /

+0.395 (+2.24%)

Chardan analyst Gbola…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCRB Seres Therapeutics
$18.01 /

+0.395 (+2.24%)

MCRB Seres Therapeutics
$18.01 /

+0.395 (+2.24%)

01/12/21 Piper Sandler
Additional Seres '109 analysis strengthens BLA filing, says Piper Sandler
12/23/20 JMP Securities
Seres Therapeutics initiated with a Market Perform at JMP Securities
11/09/20 Oppenheimer
Seres Therapeutics price target raised to $38 from $34 at Oppenheimer
11/09/20 Piper Sandler
Seres Therapeutics price target raised to $49 from $40 at Piper Sandler
MCRB Seres Therapeutics
$18.01 /

+0.395 (+2.24%)

  • 13
    Aug
Downgrade
Lendlease Group downgraded to Hold from Buy at Jefferies » 08:17
03/05/21
03/05
08:17
03/05/21
08:17
LLESY

Lendlease Group

$0.00 /

+ (+0.00%)

Jefferies analyst Sholto…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLESY Lendlease Group
$0.00 /

+ (+0.00%)

11/26/20 Credit Suisse
Lendlease Group downgraded to Neutral from Outperform at Credit Suisse
07/07/20 JPMorgan
Lendlease Group downgraded to Neutral from Overweight at JPMorgan
03/23/20 Macquarie
Lendlease Group downgraded to Neutral from Outperform at Macquarie
Recommendations
Tapestry price target raised to $45 from $36 at BMO Capital » 08:16
03/05/21
03/05
08:16
03/05/21
08:16
TPR

Tapestry

$40.75 /

-0.81 (-1.95%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPR Tapestry
$40.75 /

-0.81 (-1.95%)

TPR Tapestry
$40.75 /

-0.81 (-1.95%)

02/22/21 Credit Suisse
Tapestry upgraded to Outperform with $50 target at Credit Suisse
02/22/21 Credit Suisse
Tapestry upgraded to Outperform from Neutral at Credit Suisse
02/16/21 Piper Sandler
Tapestry price target raised to $45 from $42 at Piper Sandler
02/09/21 Telsey Advisory
Tapestry upgraded to Outperform from Market Perform at Telsey Advisory
TPR Tapestry
$40.75 /

-0.81 (-1.95%)

TPR Tapestry
$40.75 /

-0.81 (-1.95%)

TPR Tapestry
$40.75 /

-0.81 (-1.95%)

Hot Stocks
ChannelAdvisor to join Google Partners International Growth program » 08:15
03/05/21
03/05
08:15
03/05/21
08:15
ECOM

ChannelAdvisor

$21.38 /

-1.68 (-7.29%)

, GOOG

Alphabet

$2,049.59 /

+23.6 (+1.16%)

, GOOGL

Alphabet Class A

$2,034.31 /

+24.26 (+1.21%)

ChannelAdvisor (ECOM) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECOM ChannelAdvisor
$21.38 /

-1.68 (-7.29%)

GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

ECOM ChannelAdvisor
$21.38 /

-1.68 (-7.29%)

02/12/21 B. Riley Securities
ChannelAdvisor price target raised to $36 from $30 at B. Riley Securities
02/09/21 B. Riley Securities
ChannelAdvisor price target raised to $30 from $24.50 at B. Riley Securities
11/05/20 Baird
ChannelAdvisor price target lowered to $18 from $20 at Baird
10/16/20
Fly Intel: Top five analyst upgrades
GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

03/03/21 Jefferies
Google Cloud traction under Kurian 'under-appreciated,' says Jefferies
02/17/21 Morgan Stanley
Roku price target raised to $275 from $200 at Morgan Stanley
02/12/21 Citi
Citi boosts Alphabet target but shares no longer a top pick
02/08/21 Stephens
Global Payments merchant business advanced by Google pact, says Stephens
GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

03/03/21 Jefferies
Google Cloud traction under Kurian 'under-appreciated,' says Jefferies
02/17/21 Maxim
Kaleyra price target raised to $30 from $22 at Maxim
02/17/21 Morgan Stanley
Roku price target raised to $275 from $200 at Morgan Stanley
02/16/21 Loop Capital
Alphabet upgraded to Buy from Hold at Loop Capital
ECOM ChannelAdvisor
$21.38 /

-1.68 (-7.29%)

GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

General news
Employment Situation Nonfarm Payrolls to be reported at 08:30 » 08:15
03/05/21
03/05
08:15
03/05/21
08:15

February Employment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Employment Situation Unemployment Rate to be reported at 08:30 » 08:15
03/05/21
03/05
08:15
03/05/21
08:15

February Employment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
International Trade in Goods and Services Balance to be reported at 08:30 » 08:15
03/05/21
03/05
08:15
03/05/21
08:15

January International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Turtle Beach reports Q4 adjusted EPS 84c, consensus 78c » 08:14
03/05/21
03/05
08:14
03/05/21
08:14
HEAR

Turtle Beach

$28.46 /

-0.79 (-2.70%)

Last night reported Q4…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$28.46 /

-0.79 (-2.70%)

HEAR Turtle Beach
$28.46 /

-0.79 (-2.70%)

02/12/21 Maxim
Turtle Beach price target raised to $42 from $28 at Maxim
02/11/21 Stifel
Turtle Beach price target raised to $38 from $23.50 at Stifel
02/11/21 DA Davidson
Turtle Beach price target raised to $38 from $31 at DA Davidson
02/11/21 Lake Street
Turtle Beach price target raised to $40 from $30 at Lake Street
HEAR Turtle Beach
$28.46 /

-0.79 (-2.70%)

HEAR Turtle Beach
$28.46 /

-0.79 (-2.70%)

Hot Stocks
Seagen recommends shareholders reject TRC Capital mini-tender offer » 08:13
03/05/21
03/05
08:13
03/05/21
08:13
SGEN

Seagen

$145.18 /

-2.72 (-1.84%)

Seagen announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGEN Seagen
$145.18 /

-2.72 (-1.84%)

SGEN Seagen
$145.18 /

-2.72 (-1.84%)

02/16/21 RBC Capital
Seagen price target lowered to $169 from $186 at RBC Capital
02/12/21 Barclays
Seagen price target lowered to $168 from $177 at Barclays
02/12/21 Piper Sandler
Seagen price target lowered to $170 from $175 at Piper Sandler
02/01/21 RBC Capital
Seagen downgraded to Sector Perform at RBC Capital on valuation
SGEN Seagen
$145.18 /

-2.72 (-1.84%)

SGEN Seagen
$145.18 /

-2.72 (-1.84%)

Earnings
Hurco Companies reports Q1 EPS 10c vs. (13c) last year » 08:12
03/05/21
03/05
08:12
03/05/21
08:12
HURC

Hurco Companies

$30.85 /

-0.95 (-2.99%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HURC Hurco Companies
$30.85 /

-0.95 (-2.99%)

Recommendations
Jamf Holding price target raised to $49 from $45 at RBC Capital » 08:12
03/05/21
03/05
08:12
03/05/21
08:12
JAMF

Jamf Holding

$36.45 /

-1.33 (-3.52%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

06:39 Today Mizuho
Jamf Holding price target raised to $45 from $43 at Mizuho
01/28/21 Piper Sandler
Jamf Holding remains a top idea for 2021 at Piper Sandler
01/05/21 Canaccord
Jamf Holding metrics 'bode well' for strong Q4, says Canaccord
09/02/20 Canaccord
Jamf Holding upside likely in Q3, says Canaccord
JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

  • 19
    Nov
  • 22
    Jul
JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

Recommendations
Market undervaluing Durect's alcoholic hepatitis opportunity, says Chardan » 08:12
03/05/21
03/05
08:12
03/05/21
08:12
DRRX

Durect

$2.05 /

-0.13 (-5.96%)

Chardan analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DRRX Durect
$2.05 /

-0.13 (-5.96%)

DRRX Durect
$2.05 /

-0.13 (-5.96%)

02/03/21 Jefferies
Posimir should not be significant threat to Pacira's Exparel, says Jefferies
02/03/21 Chardan
Chardan boosts Durect target to $8 with 'final overhang' removed
02/02/21 Oppenheimer
Posimir approval a 'significant positive' for Durect, says Oppenheimer
02/02/21 Roth Capital
Roth reiterates $7 target on Durect after 'surprise' FDA approval
DRRX Durect
$2.05 /

-0.13 (-5.96%)

  • 04
    Feb
DRRX Durect
$2.05 /

-0.13 (-5.96%)

Hot Stocks
Virgin Galactic down 7% after Palihapitiya sells 6.2M shares » 08:11
03/05/21
03/05
08:11
03/05/21
08:11
SPCE

Virgin Galactic

$30.29 /

-1.72 (-5.37%)

Chamath Palihapitiya,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

03/03/21 BofA
Virgin Galactic price target raised to $50 from $35 at BofA
02/26/21 Alembic Global
Virgin Galactic downgraded to Neutral from Overweight at Alembic Global
02/26/21 UBS
Virgin Galactic price target lowered to $40 from $52 at UBS
02/09/21 UBS
Virgin Galactic downgraded to Neutral from Buy at UBS
SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

  • 06
    Aug
  • 03
    Jun
  • 20
    May
SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

Hot Stocks
Huntington Ingalls appoints Kari Wilkinson as president, Shipbuilding division » 08:11
03/05/21
03/05
08:11
03/05/21
08:11
HII

Huntington Ingalls

$179.32 /

-3.55 (-1.94%)

Huntington Ingalls…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HII Huntington Ingalls
$179.32 /

-3.55 (-1.94%)

HII Huntington Ingalls
$179.32 /

-3.55 (-1.94%)

01/06/21 Vertical Research
Huntington Ingalls downgraded to Hold from Buy at Vertical Research
12/04/20 Alembic Global
Huntington Ingalls upgraded to Overweight from Neutral at Alembic Global
10/02/20 JPMorgan
Huntington Ingalls price target lowered to $175 from $205 at JPMorgan
10/01/20 Barclays
Huntington Ingalls price target lowered to $160 from $190 at Barclays
HII Huntington Ingalls
$179.32 /

-3.55 (-1.94%)

HII Huntington Ingalls
$179.32 /

-3.55 (-1.94%)

Hot Stocks
Hanesbrands appoints Tracy Preston general counsel, chief compliance officer » 08:11
03/05/21
03/05
08:11
03/05/21
08:11
HBI

Hanesbrands

$18.44 /

-0.35 (-1.86%)

HanesBrands announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBI Hanesbrands
$18.44 /

-0.35 (-1.86%)

HBI Hanesbrands
$18.44 /

-0.35 (-1.86%)

02/10/21 B. Riley Securities
Hanesbrands price target raised to $22 from $19 at B. Riley Securities
02/10/21 Barclays
Hanesbrands price target raised to $26 from $16 at Barclays
01/21/21 Deutsche Bank
Hanesbrands price target raised to $16 from $14 at Deutsche Bank
12/14/20
Fly Intel: Top five analyst downgrades
HBI Hanesbrands
$18.44 /

-0.35 (-1.86%)

HBI Hanesbrands
$18.44 /

-0.35 (-1.86%)

HBI Hanesbrands
$18.44 /

-0.35 (-1.86%)

Recommendations
Purple Innovation price target lowered to $32 from $38 at Wedbush » 08:09
03/05/21
03/05
08:09
03/05/21
08:09
PRPL

Purple Innovation

$24.42 /

-11.76 (-32.50%)

Wedbush analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

08:05 Today Raymond James
Purple Innovation price target lowered to $32 from $36 at Raymond James
06:21 Today UBS
Purple Innovation price target lowered to $32 from $44 at UBS
01/12/21 B. Riley Securities
Purple Innovation price target raised to $41 from $20 at B. Riley Securities
01/12/21 Wedbush
Purple Innovation price target raised to $38 from $32 at Wedbush
PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

  • 10
    Sep
  • 15
    May
PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

Hot Stocks
Second Sight receives FDA approval for Argus 2s Retinal Prosthesis System » 08:09
03/05/21
03/05
08:09
03/05/21
08:09
EYES

Second Sight

$1.43 /

-0.29 (-16.86%)

Second Sight announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYES Second Sight
$1.43 /

-0.29 (-16.86%)

EYES Second Sight
$1.43 /

-0.29 (-16.86%)

04/01/20 H.C. Wainwright
Second Sight rating placed under review at H.C. Wainwright
  • 01
    May
Hot Stocks
Brickell Biotech to host KOL webinar on the hyperhidrosis market » 08:08
03/05/21
03/05
08:08
03/05/21
08:08
BBI

Brickell Biotech

$1.17 /

+ (+0.00%)

Brickell Biotech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBI Brickell Biotech
$1.17 /

+ (+0.00%)

BBI Brickell Biotech
$1.17 /

+ (+0.00%)

09/25/20 Lake Street
Approval in Japan validating for Brickell Biotech, says Lake Street
08/28/20 Lake Street
Brickell Biotech initiated with a Buy at Lake Street
08/25/20 Oppenheimer
Brickell Biotech initiated with an Outperform at Oppenheimer
  • 23
    Oct
  • 18
    Jun
Hot Stocks
Fathom acquires real estate brokerage business of Red Barn Real Estate » 08:08
03/05/21
03/05
08:08
03/05/21
08:08
FTHM

Fathom

$34.78 /

-5.22 (-13.05%)

Fathom Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTHM Fathom
$34.78 /

-5.22 (-13.05%)

FTHM Fathom
$34.78 /

-5.22 (-13.05%)

02/10/21 Roth Capital
Roth raises Fathom target to $52, sees 'multifold benefits' from Naberly deal
02/09/21 DA Davidson
Fathom initiated with a Buy at DA Davidson
01/25/21 Roth Capital
Fathom price target raised to $50 from $40 at Roth Capital
12/28/20 Roth Capital
Fathom price target raised to $40 from $28 at Roth Capital
  • 28
    Jul
Hot Stocks
Immutep expands Part B of TACTI-002 Phase II study » 08:07
03/05/21
03/05
08:07
03/05/21
08:07
IMMP

Immutep

$2.41 /

-0.2 (-7.66%)

Immutep is pleased to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMMP Immutep
$2.41 /

-0.2 (-7.66%)

IMMP Immutep
$2.41 /

-0.2 (-7.66%)

01/26/21 Alliance Global Partners
Immutep price target raised to $6 from $5 at Alliance Global Partners
12/14/20 Maxim
Maxim doubled Immutep price target after breast cancer update
11/11/20 Maxim
Immutep price target raised to $4 from $2 at Maxim
09/22/20
Top five analyst initiations
IMMP Immutep
$2.41 /

-0.2 (-7.66%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.